Skip to content

Clinical trials

Hyperoxaluria, Primary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperoxaluria, Primary Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20072
20091
20134
20162
20172
20183
20194
20202
20211
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting6
Active, not recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic9
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company5
OxThera4
Alnylam Pharmaceuticals3
Allena Pharmaceuticals1
Arbor Biotechnologies1
NYU Langone Health1
Novo Nordisk A/S1
VA New York Harbor Healthcare System1
YolTech Therapeutics Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperoxaluria, Primary27
Hyperoxaluria14
Cystinuria5
Dent Disease5
Kidney Calculi4
Genetic Diseases, Inborn2
Kidney Diseases2
Nephrocalcinosis2
Urologic Diseases2
Oculocerebrorenal Syndrome1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.